¡¡
Pharma Koreana, Korea pharmaceutical news & reports, was established in 1991 and is now Korean leading pharmaceutical business newsletter. For the past years, Pharma Koreana has consistently provided senior executives in the pharmaceutical industry with the inside knowledge they need to compete and win! Readers are subscribers at the pinnacle of their careers as well as the rising stars of tomorrow. They turn to Pharma Koreana for its unique monthly package of Korean pharmaceutical news, analyses, commentaries and data. ¡¡
          
¡¡

News search results
There are '3594' news items matching your search for 'Policy and Regulatory'

1. GSK Korea¡¯s Votrient for the treatment of renal cell carcinoma approved by the KFDA

GSK Korea recently obtained the KFDA approval for Votrient (pazopanib) for the treatment of advanced renal cell carcinoma (RCC). Votrient, a ..
 

August 31st, 2010
2. National inspection of 23 seasonal influenza vaccines completed

The KFDA announced that it has conducted national inspection (national lot release testing) of 23 seasonal influenza vaccines from 10 vaccin ..
 

August 31st, 2010
3. Pharmaceutical firms seeking for various solutions to the government¡¯s plan for no reimbursement for use of OTC drugs

The Health Insurance Review Agency (HIRA) plans to refer the results of ¡®evaluation of medical insurance based reimbursement of 1,800 differ ..
 

August 24th, 2010
4. New classification system of drug formulations to be included in the fifth revised edition of the Korean Pharmacopoeia

The KFDA announced that it will prepare a new classification system of drug formulations and will include the new system into the fifth revi ..
 

August 24th, 2010
5. Reimbursement criteria for narcotics to be reformulated

The Health Insurance Review Agency (HIRA) plans to assess the use of narcotic and psychotropic drugs through electronic data processing. In ..
 

August 24th, 2010
6. Protocols for bioequivalence testing of generic versions of Olmetec Plus approved

According to ¡®the status of approval for protocols for bioequivalence testing¡¯ made public on a weekly basis, the KFDA approved protocols fo ..
 

August 24th, 2010
7. KFDA to operate a website for the laboratory animal system

The KFDA presented the content of the Laboratory Animal Law at ¡®2010 Korean Association for Laboratory Animal Science (KALAS) International ..
 

August 24th, 2010
8. UCB Korea¡¯s Vimpat for the treatment of epilepsy approved by the KFDA

UCB Korea recently obtained the KFDA approval for Vimpat (lacosamide) tab. for the treatment of epilepsy. Vimpat can be used for the treatme ..
 

August 24th, 2010
9. Korea Green Cross¡¯ PeramiFlu for the treatment of influenza approved by the KFDA

Korea Green Cross recently obtained the KFDA approval for PeramiFlu (peramivir 300mg) inj. for the treatment of influenza. Korea Green Cross ..
 

August 24th, 2010
10. BRN Science receives GMP certification for its new plant from the KFDA

BRN Science recently announced that it received GMP certification for its new plant in Jecheon City from the KFDA. BRN Science stated that t ..
 

August 24th, 2010
11. Rapamune expected to be reimbursed from October 2010

The National Health Insurance Corporation (NHIC) said that price negotiations for 23 drug products, representing 16 drug compounds, are unde ..
 

August 17th, 2010
12. Transparency and fairness of national R&D projects to be enhanced

The Ministry of Education, Science and Technology (MEST) announced that a total revision of executive order for ¡®the management of national ..
 

August 17th, 2010
13. Effient, a next-generation anti-platelet drug, approved by the KFDA

Lilly Korea and Daiichi Sankyo Korea announced that the KFDA recently approved Effient (prasugrel), a next-generation anti-platelet drug. Ef ..
 

August 17th, 2010
14. Pharmaceutical firms expected to strictly manage supply prices of their flagship products

 In connection with the implementation of ¡®market-driven drug price control system based on actual transacted drug prices¡¯ from October ..
 

August 17th, 2010
15. Protocols for bioequivalence testing of generic versions of Amaryl M approved

According to ¡®the status of approval for protocols for bioequivalence testing¡¯ made public on a weekly basis, the KFDA approved protocols fo ..
 

August 17th, 2010
[1] 2 3 4 5 6 7 8 9 10
¡¡
Pharma Koreana Ltd. 14th floor, KTB Network Bldg., 826-14, Yeoksam, Kangnam-gu, Seoul135-080 ,KOREA Tel:(82)2-554-9591 Fax:(82)2-563-8289 ¡¡ ¡¡

Email:Pkinfo@Pharmakoreana.com
Subscriptions:Pkinfo@Pharmakoreana.com
¡¡
¡¡